2-(MERCAPTOMETHYL)-4-METHOXY-1-(6-METHOXY-1H-BENZIMIDAZOL-2-YL)-3,5-DIMETHYLPYRIDINIUM
UNII 6BTN3S46UW
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(mercaptomethyl)-4-methoxy-1-(6-methoxy-1h-benzimidazol-2-yl)-3,5-dimethylpyridinium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6BTN3S46UW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 125656-79-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H20N3O2S JKVAPRUOVGZUFY-UHFFFAOYSA-O Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(mercaptomethyl)-4-methoxy-1-(6-methoxy-1h-benzimidazol-2-yl)-3,5-dimethylpyridinium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.